Sort
78,016 grants matching “breast cancer”
RCT OF PLANT-BASED DIET IN BREAST CANCER RECURRENCE
$854,170University Of California San Diego · R01 · FY2003 · CA
Flaxseed effects on hormones and lignans: role of race, genes, and gut microbiome
$854,101Susan E McCann · Roswell Park Cancer Institute Corp · U01 · FY2014 · CA
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
$854,013Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
A comprehensive imaging solution for dense breast cancer screening and diagnostics
$853,988Peymon Ghazi · Malcova Inc · R44 · FY2025 · CA
PREVENTION AND TREATMENT OF BREAST CANCER AND ITS METASTASIS BY TARGETING MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)
$853,905Ohio State University, The · · FY2016 · Department of the Army
Combined Digital X-Ray, Optical, and Ultrasound Breast Imaging
$853,883Paul L Carson · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE
$853,881 · N01 · FY2013 · HD
NCI NCTN-Network Lead Academic Site at UPCI
$853,523Adam M Brufsky · University Of Pittsburgh At Pittsburgh · U10 · FY2016 · CA
Breast CT scanner for earlier cancer detection
$853,472John M Boone · University Of California At Davis · R01 · FY2006 · EB
A GENETIC AND METABOLIC BASIS FOR HORMONALLY DRIVEN POSTMENOPAUSAL BREAST CANCER
$853,377The Cleveland Clinic Foundation · · FY2022 · Defense Health Agency
Systematic Light Exposure to treat Cancer-Related Fatigue in Breast Cancer Patients
$853,349William H Redd · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Clinical trials employing cancer vaccine combination therapies
$853,223James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$853,223James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Physiological and pathological functions of E3 ubiquitin ligases Smurfs
$853,050Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
HDAC/PI3K Dual Inhibitors for Treatment of Rare Cancers
$853,006Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Human Immune Responses to Tumor Antigens for Cancer Vaccine Development
$852,537Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Appraisal and Diagnostic Delay in Colon Cancer
$852,467Laura A Siminoff · Virginia Commonwealth University · R01 · FY2010 · CA
Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer
$852,459Carol J Fabian · University Of Kansas Medical Center · R01 · FY2021 · CA
Illinois Oncology Research Association Community Clinical Oncology Program
$852,293Nguyet A. Le-Lindqwister · Oncology-Hematology Assoc-Central Ill · U10 · FY2013 · CA
TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis
$852,124Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2021 · CA
Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers
$852,093Thea D Tlsty · University Of California, San Francisco · R35 · FY2020 · CA
Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers
$852,086Thea D Tlsty · University Of California, San Francisco · R35 · FY2021 · CA
Meiotic Chromosome Synapsis and Recombination in Yeast
$852,075Nancy E. Kleckner · Harvard University · R01 · FY2018 · GM
Identifying non-coding RNAs for early detection and prevention of lung cancer
$851,643Carlo M Croce · Ohio State University · U01 · FY2014 · CA
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
$851,597Joan Siefert Brugge · Harvard Medical School · R35 · FY2021 · CA